Klinikum der Universität Augsburg (Universitätsklinikum Augsburg) Institut für Humangenetik

29 capabilities Accredited since May 2026 Verified May 2026 One of 3,056 in Germany

Details

Stenglinstraße 2
Augsburg 86156 , Germany

Accreditation

Active DAkkS D-ML-13136-01-01

Accreditation Details

Accreditation Body

DAkkS

Number

D-ML-13136-01-01

Status

Active

Since

04 May 2026

Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.

Download Scope PDF

29 capabilities

Send an Enquiry

Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.

Your name *

Your email *

Company *

Test method / standard Please select a test method from the list

Material / sample type

Number of samples / specimens

Timeline

Volume

Additional details (optional)

Klinikum der Universität Augsburg (Universitätsklinikum Augsburg) Institut für Humangenetik

DAkkS № D-ML-13136-01-01

Direct & private Your message goes straight to the lab

No obligation Free to enquire, no commitment required

What happens next?

We send your enquiry to the lab
The lab will review your enquiry and reply directly to your email
You agree on testing scope, timeline, and pricing

Test Capabilities (29)

Standard Reference	Description	Category
(DICER1 ); SNV, CNV	(DICER1 ); SNV, CNV	Molecular Diagnostics / PCR
(PDGFRB, NOTCH3 ); SNV, CNV	(PDGFRB, NOTCH3 ); SNV, CNV	Molecular Diagnostics / PCR
1/4 (DKN1B, MEN1 ); SNV, CNV	1/4 (DKN1B, MEN1 ); SNV, CNV	Molecular Diagnostics / PCR
Brust- und Eierstockkrebs	Familiärer Brust- und Eierstockkrebs	Molecular Diagnostics / PCR
DICER1-assozierte Tumordisposition	DICER1-assozierte Tumordisposition	Molecular Diagnostics / PCR
Darmkrebs, adenomatöse Polyposis	Darmkrebs, adenomatöse Polyposis	Molecular Diagnostics / PCR
Endometriumkarzinom (FH, MLH1, MSH2, MSH6, PMS2, PTEN, EPCAM, MUTYH, NTHL1, POLD1, POLE, SMAD4 ); SNV, CNV	Endometriumkarzinom (FH, MLH1, MSH2, MSH6, PMS2, PTEN, EPCAM, MUTYH, NTHL1, POLD1, POLE, SMAD4 ); SNV, CNV	Molecular Diagnostics / PCR
Infantile Myofibromatose	Infantile Myofibromatose	Molecular Diagnostics / PCR
MSH2, MSH6, MUTYH, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53	MSH2, MSH6, MUTYH, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53	Molecular Diagnostics / PCR
Multiple Endokrine Neoplasie Typ	Multiple endokrine Neoplasie Typ	Molecular Diagnostics / PCR
Paragangliom, Phäochromozytom	Paragangliom, Phäochromozytom	Molecular Diagnostics / PCR
Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV	Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV	Molecular Diagnostics / PCR
Syndrom (PTEN ); SNV, CNV	Syndrom (PTEN ); SNV, CNV	Molecular Diagnostics / PCR
(TruSight Oncology 500 v2) (RET	(TruSight Oncology 500 v2) (RET	Other
8,17,29,50,63), SAR1B, SCARB1, SMPD1, SORT1, SPRTN, USF1, WRN, ZMPSTE24; CNV: LDLR, LPL)	8,17,29,50,63), SAR1B, SCARB1, SMPD1, SORT1, SPRTN, USF1, WRN, ZMPSTE24; CNV: LDLR, LPL)	Other
ATM, BRCA1,…,TP53); SNV, CNV	ATM, BRCA1,…,TP53); SNV, CNV	Other
Birt-Hogg-Dubé-Syndrom (FLCN	Birt-Hogg-Dubé-Syndrom (FLCN	Other
Foundervariante); SNV, CNV	Foundervariante); SNV, CNV	Other
MSH2, MSH6, EPCAM ); SNV, CNV	MSH2, MSH6, EPCAM ); SNV, CNV	Other
Noonan-Syndrom Basis (PTPN11	Noonan-Syndrom Basis (PTPN11	Other
POLE ); SNV, CNV	POLE ); SNV, CNV	Other
PTCH1 ); SNV, CNV	PTCH1 ); SNV, CNV	Other
Pankreaskarzinom, familiäres (APC	Pankreaskarzinom, familiäres (APC	Other
Peutz-Jeghers-Syndrom (STK11	Peutz-Jeghers-Syndrom (STK11	Other
RAD51D, HOXB13-	RAD51D, HOXB13-	Other
SMARCB1 ); SNV, CNV	SMARCB1 ); SNV, CNV	Other
Tuberöse Sklerose (TSC1, TSC2	Tuberöse Sklerose (TSC1, TSC2	Other
VHL, BAP1, TSC1, TSC2 ); SNV, CNV	VHL, BAP1, TSC1, TSC2 ); SNV, CNV	Other
bearbeitet und analysiert.	bearbeitet und analysiert.	Other

Report incorrect or outdated information